{
  "retracted": false,
  "timestamp": 1527811200000,
  "updates": [
    {
      "timestamp": 1574841259596,
      "identifier": {
        "doi": "10.1007/s40273-018-0676-8"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s40273-018-0641-6"
  },
  "journal": "PharmacoEconomics",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin"
}
